Hepatitis C Global Market Size Forecasted to Reach $134.03 Billion by 2029 as it Booms at a CAGR of 15.1% According to New Report

 

The global Hepatitis C market size has experienced rapid growth in recent years. It will grow from $67.17 billion in 2024 to $76.32 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to blood transfusion practices, injection drug use, limited treatment options, and development of direct-acting antivirals (DAAs).

The Hepatitis C market size is expected to continue its rapid growth over the next few years, reaching $134.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The forecasted growth can be attributed to global elimination efforts, improved testing and screening, rising healthcare spending, integration of telemedicine, emerging therapeutic combinations. Major trends in the forecast period include accessible and affordable treatment, focus on high-risk groups, improved drug formulations, collaborative efforts and partnerships, telehealth and digital solutions.

Click to Get Your Free Sample of The Global Hepatitis C Global Market Report 2024 Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp

What Are The Main Drivers of Growth in The Hepatitis C Market?
An increase in viral infections contributes significantly to the growth of the hepatitis C market. Viral infections impact the body, and hepatitis C treatment can reduce the viral load and restore the immune response in patients after achieving viral clearance. For instance, in August 2024, the Centers for Disease Control and Prevention reported a marked increase in the prevalence of Parvovirus B19 infections across all age groups, especially children aged 5–9 years. This escalation in viral infections is a key driver in the hepatitis C market.

How Is the Global Hepatitis C Market Segmented?
The Hepatitis C market including the following segments:
1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types
2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments
3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis
4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings

Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Which Major Players Are Operating in The Hepatitis C Market?
Emerging players in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited.

What Trends Are Impacting the Hepatitis C Market?
Diagnostic advances are a key emerging trend in the hepatitis C market. Companies are leveraging new technologies such as the Elecsys HCV Duo immunoassay from F. Hoffmann-La Roche Ltd. These innovative tools allow for both antigen and antibody testing from a single sample. Identifying patients recovering or exhibiting symptoms of a chronic infection that may result in other diseases, such as liver cancer and early-stage conditions, is now more efficient and accurate.

What Does the Regional Analysis Show for The Hepatitis C Market?
In 2024, North America held the largest market share in the hepatitis C market. However, Asia-Pacific is predicted to be the fastest-growing region in the future. The other regions covered in the hepatitis C market report are Western Europe, Eastern Europe, South America, Middle East, and Africa.

How Does The Hepatitis C Global Market Report 2024-2025 Classify the Hepatitis C Market?
Hepatitis C primarily affects the liver, leading to inflammation, liver damage, and potentially cirrhosis or liver cancer if untreated. It spreads through contact with infected blood and is treated using antiviral medications aimed at eradicating the virus from the bloodstream. The Hepatitis C Global Market Report 2024, courtesy of The Business Research Company, offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more